US Patent 10131904 Modified RNAi polynucleotides and uses thereof
Patent 10131904 was granted and assigned to Rxi Pharmaceuticals Corporation on November, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10131904 Modified RNAi polynucleotides and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.